Loading peptide…
PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.
Also known as: Bromantane
Bromantane is an adamantane-derived actoprotector with mild stimulant and anxiolytic properties, used clinically in Russia (as Ladasten) for asthenia and fatigue. It is a small-molecule research chemical, not a peptide, in most other markets. Note: Bromantane is a small-molecule actoprotector, not a peptide, though it is often catalogued with research peptides.
Sign in to rate this peptide.
Bromantane is an atypical, indirectly acting dopaminergic agent that upregulates the biosynthetic enzymes tyrosine hydroxylase and aromatic L-amino acid decarboxylase, increasing dopamine synthesis in the hypothalamus and other regions. This gradual enhancement of dopaminergic and, secondarily, serotonergic neurotransmission underlies its combined stimulant and anxiolytic ('actoprotector') profile, improving endurance and stress resistance without the sharp peaks of classical psychostimulants. It also exhibits mild immunostimulant activity and supports physical work capacity under hypoxic or high-load conditions.